These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35129895)

  • 41. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?
    Shen JJ; Arendrup MC; Verma S; Saunte DML
    Dermatology; 2022; 238(1):60-79. PubMed ID: 34058736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tinea corporis due to Trichophyton tonsurans Malmsten--report of a patient from Zaire.
    Nenoff P; Haustein UF
    Mycoses; 1997 Sep; 40(3-4):127-9. PubMed ID: 9375501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis.
    Smith EB
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S24-S28. PubMed ID: 8496408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological study of terbinafine-resistant dermatophytes isolated from Japanese patients.
    Hiruma J; Noguchi H; Hase M; Tokuhisa Y; Shimizu T; Ogawa T; Hiruma M; Harada K; Kano R
    J Dermatol; 2021 Apr; 48(4):564-567. PubMed ID: 33439506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Terbinafine Resistant
    Posso-De Los Rios CJ; Tadros E; Summerbell RC; Scott JA
    J Cutan Med Surg; 2022; 26(4):371-376. PubMed ID: 35144480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Terbinafine exacerbates psoriasis: case report with a literature review.
    Szepietowski JC
    Acta Dermatovenerol Croat; 2003; 11(1):17-21. PubMed ID: 12718791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Test your knowledge. Tinea corporis.
    Haider MT; Bennett GC
    J Tissue Viability; 1999 Apr; 9(2):69-71. PubMed ID: 10480975
    [No Abstract]   [Full Text] [Related]  

  • 52. Targetoid bullous tinea corporis: Unusual presentation of a dermatophyte infection.
    Lim SYD; Lee JSS; Chong WS
    Indian J Dermatol Venereol Leprol; 2021; 87(1):101-103. PubMed ID: 33063704
    [No Abstract]   [Full Text] [Related]  

  • 53. Eyelid tinea with blepharitis due to Microsporum canis.
    Calles Monar PS; Juárez Martín A
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):491-493. PubMed ID: 29859733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
    Chatterjee D; Ghosh SK; Sen S; Sarkar S; Hazra A; De R
    Indian J Pharmacol; 2016; 48(6):659-664. PubMed ID: 28066103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.
    Saunte DML; Pereiro-Ferreirós M; Rodríguez-Cerdeira C; Sergeev AY; Arabatzis M; Prohić A; Piraccini BM; Lecerf P; Nenoff P; Kotrekhova LP; Bosshard PP; Padovese V; Szepietowski JC; Sigurgeirsson B; Nowicki RJ; Schmid-Grendelmeier P; Hay RJ
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1582-1586. PubMed ID: 33768571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis.
    Zaias N; Berman B; Cordero CN; Hernandez A; Jacobson C; Millikan L; Rojas R; de la Rosa I; Villars V; Birnbaum JE
    J Am Acad Dermatol; 1993 Oct; 29(4):646-8. PubMed ID: 8408803
    [No Abstract]   [Full Text] [Related]  

  • 59. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Common tinea infections in children.
    Andrews MD; Burns M
    Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.